- Home
- LNG vs NNVC Comparison
LNG vs NNVC Comparison
Compare LNG & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNG
- NNVC
- Stock Information
- Founded
- LNG 1983
- NNVC 2005
- Country
- LNG United States
- NNVC United States
- Employees
- LNG N/A
- NNVC N/A
- Industry
- LNG Oil/Gas Transmission
- NNVC Biotechnology: Pharmaceutical Preparations
- Sector
- LNG Utilities
- NNVC Health Care
- Exchange
- LNG Nasdaq
- NNVC Nasdaq
- Market Cap
- LNG 53.9B
- NNVC 24.4M
- IPO Year
- LNG 1997
- NNVC N/A
- Fundamental
- Price
- LNG $241.68
- NNVC $1.37
- Analyst Decision
- LNG Strong Buy
- NNVC
- Analyst Count
- LNG 14
- NNVC 0
- Target Price
- LNG $253.64
- NNVC N/A
- AVG Volume (30 Days)
- LNG 2.0M
- NNVC 240.8K
- Earning Date
- LNG 08-07-2025
- NNVC 05-15-2025
- Dividend Yield
- LNG 0.82%
- NNVC N/A
- EPS Growth
- LNG N/A
- NNVC N/A
- EPS
- LNG 13.71
- NNVC N/A
- Revenue
- LNG $16,739,000,000.00
- NNVC N/A
- Revenue This Year
- LNG $33.47
- NNVC N/A
- Revenue Next Year
- LNG $12.47
- NNVC N/A
- P/E Ratio
- LNG $17.69
- NNVC N/A
- Revenue Growth
- LNG N/A
- NNVC N/A
- 52 Week Low
- LNG $167.66
- NNVC $0.94
- 52 Week High
- LNG $257.65
- NNVC $2.55
- Technical
- Relative Strength Index (RSI)
- LNG 57.45
- NNVC 36.88
- Support Level
- LNG $229.35
- NNVC $1.36
- Resistance Level
- LNG $240.97
- NNVC $1.46
- Average True Range (ATR)
- LNG 6.29
- NNVC 0.09
- MACD
- LNG 0.21
- NNVC -0.03
- Stochastic Oscillator
- LNG 79.48
- NNVC 19.05
About LNG Cheniere Energy Inc.
Cheniere Energy is a liquified natural gas, or LNG, producer with two facilities in Corpus Christi, Texas and Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed and variable fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. A subsidiary, Cheniere Energy Partners, owns the Sabine Pass facility and trades as a master limited partnership.
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.